Satellite symposium held to boost Eye Care Professionals’ confidence in MiYOSMART  spectacle lenses 

HOYA Vision Care, a leader in optical technology innovation,  took part in the 15th annual conference of the European Academy of Optometry and Optics  (EAOO) held on the 10-12th May 2024 in Helsinki, Finland. Honouring their commitment to  share knowledge and technical advances in the field of myopia management, HOYA Vision  Care, a platinum event sponsor, hosted a satellite symposium, Confidence through Evidence – MiYOSMART in Daily Practice.  

The symposium was kicked off with a talk by Dr. Rakhee Shah, Global Scientific and Medical  Affairs Manager at HOYA Vision Care, who spoke of the importance of credible evidence for  patients, parents, and Eye Care Professionals (ECPs) in myopia management. Dr. Shah also  shared the six key areas to empower ECPs to meet the diverse needs of their patients. 

Professor Kathryn Saunders, Subject Lead for Optometry & Vision Science at Ulster  University, then shared her findings on the predictability of myopia progression in UK children aged 5-15 years old. The analysis found that the change in axial length within the first six months of MiYOSMART wear was significantly predictive of future axial elongation. Prof. Saunders also reported that faster progression in axial length within the first six-months is  likely to result in fast progression in the subsequent 12-months. She also revealed that the progression in spherical equivalent refraction in the first six-months was a poorer predictor of  future myopia progression.  

The symposium concluded with Marianne Goldwaser, Professional Affairs Manager at HOYA  Vision Care, presenting the results of the Early Experience Programme (EEP), a post-marketing  study of MiYOSMART Chameleon photochromic spectacle lenses. The EEP, conducted  between July 2023 and January 2024, aimed to gain insights of the experience with  MiYOSMART Chameleon directly from the patients. The focus was on adaptation and  tolerability in young patients of different ages and ethnicities, satisfaction and compliance, and 

outdoor behaviour.1The stand-out statistics gathered by the EEP was patient satisfaction at the  three-month point, showing that 98% (n=55) of wearers in the programme were satisfied with  their MiYOSMART Chameleon spectacle lenses.1 This high satisfaction rate is likely to translate to higher treatment adherence, both indoors and outdoors, which in turn has the  potential of maximizing the effectiveness of myopia management in children. 

Over seven million MiYOSMART spectacle lenses have been sold worldwide since their  launch in 2018.2 HOYA Vision Care is committed to fighting and controlling the growing  problem of myopia around the world by continually conducting evidence-based research on  the MiYOSMART spectacle lenses and sharing industry knowledge and professional insights  in the field of myopia treatment. 

Product Disclaimer: MiYOSMART spectacle lenses have not been approved for use in the  management of Myopia in all countries, including the U.S., and are not currently available for sale in  all countries, including the U.S. 

# # # 

About HOYA Vision Care  

As a global leader in optical technology, HOYA Vision Care is dedicated to providing  innovative vision care solutions for every stage of a patient’s life. A steadfast partner to Eye  Care Professionals around the world, it stands at the forefront of optical excellence. With a  global presence, consisting of 43 laboratories and a growing team of 20,000 employees,  HOYA Vision Care delivers innovative lenses and other vision care solutions to millions of  people in 110 countries. 


  1. HOYA data on file : Post Market Surveillance “Early Experience Program of MiYOSMART  sun spectacle lenses”. 02/2024 
  2. Based on number of MiYOSMART spectacle lenses sold as per HOYA sales data on file as of  December 2023. 

For further information (not for print) please contact: 

HOYA Vision Care PR  

Name: Susan Brown  


M: +1 831.233.4616  

Follow HOYA Vision Care on Linkedin